Aladdin Healthcare Technologies SE announced that Professor David C. Rubinsztein has been appointed as Chief Scientific Advisor. David is the Deputy Director of the Cambridge University Institute of Medical Research, Professor of Molecular Neurogenetics and Wellcome Trust Principal Research Fellow. His research interests are in autophagy and neurodegeneration.